Search Results

Abyrx, Inc. today announced that the United States Food and Drug Administration (FDA) has provided regulatory clearance for the company’s MONTAGE® Settable Bone Putty for use in cardiothoracic surgery following sternotomy.

Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for use during surgical procedures, today announced its receipt of additional United States Food and Drug Administration (FDA) clearances for the company’s MONTAGE® Settable, Resorbable Bone Putty as both a bone void filler and cranial bone cement

Former Director of the U.S. National Economic Council and Goldman Sachs COO joins biomaterial sciences company Board of Directors

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global bone wax market was valued at US$ 68.8 Mn in 2017 and is projected to expand at a CAGR of 2% from 2018 to 2026 to reach US$ 84.2 Mn in 2026.